Nine Inch Nails front man Trent Reznor is taking his own dislike of the record industry and the new standard by Radiohead to the next level by releasing a collaboration album with Saul Williams for free on the internet, according to NME. The album, The Inevitable Rise and Liberation of Niggy Tardust, will be released on a special site for the album on November 1 and cost fans zilch. Billboard notes that a $5 donation for the album will be optional, but allows the consumer to get a "higher quality digital format" while either purchase will be free of Digital Rights Management technology.
The impact of this album may not be as influential or large as the Radiohead release a couple of weeks ago, but the effects are clearly starting to ripple through the music industry. Reznor states on the Nine Inch Nails website that the goal was to "improve upon [Radiohead's] idea" and "benefit the consumer," which is obvious from the obvious free choice. Reznor is also careful to mention that their situation is different from Radiohead's because "Saul Williams is not a household name" and they need fan support.
In the new era of digital music that is dawning, fan and consumer support will obviously be vital. If artists are willing to keep album prices down, then the success of this "revolution" will be insured. Unfortunately, it looks like no matter how many large acts get involved the work will be for the less known artists to make the new model work. In the end, the novelty of such moves will wear off, but if the labels can find a middle ground, the fans may embrace that method as well.
Last updated: February 10, 2012: 05:06 PM
Hot Stocks
DailyFinance Headlines
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
Benzinga Headlines
- Michigan Consumer Sentiment Index Drops
- Don't Bank on Barclays
- GSV Capital Punished for Expanding Facebook Investment
- Chesapeake Gently Lets Go of Gas
- How to Profit off Addicts
TheFlyOnTheWall.com Headlines
- January New Home Sales to be released at 10:00 ET
- February Consumer Sentiment to be released at 09:55 ET
- Churchill Downs acquires assets of Bluff Media
- Mario Monti: Far from certain there will be a Greek default, CNBC reports
- Energen to acquire proved Wolfberry properties
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
WalletPop Headlines
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Business News
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
Savings Experiment: Snow Removal
Why Your 2012 Tax Bill May Jump By $8,000

